Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CB 300919 is a quinazoline-based antitumor agent with high activity in the CH1 human ovarian tumor xenograft and has continuous exposure (96 h) growth inhibition (IC50: 2 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,140.00 | |
50 mg | 10-14 weeks | $ 1,490.00 | |
100 mg | 10-14 weeks | $ 2,250.00 |
Description | CB 300919 is a quinazoline-based antitumor agent with high activity in the CH1 human ovarian tumor xenograft and has continuous exposure (96 h) growth inhibition (IC50: 2 nM). |
Molecular Weight | 584.11 |
Formula | C32H34ClN7O2 |
CAS No. | 289715-28-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (171.20 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CB 300919 289715-28-2 Others CB-300919 CB300919 inhibitor inhibit